World J Urol. 2006 Nov;24(5):585-90. Epub 2006 Jul 19.

Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.

Blana A, Rogenhofer S, Ganzer R, Wild PJ, Wieland WF, Walter B.

Source

Department of Urology, University of Regensburg, St. Josef Hospital, Landshuterstrasse 65, 93053 Regensburg, Germany. blana@caritasstjosef.de

Abstract

The aim of this cross-sectional study was to compare single with repeated high-intensity focused ultrasound (HIFU) treatment in patients with localized prostate cancer, regarding treatment-related morbidity. A number of 223 consecutive patients with localized prostate cancer were treated with HIFU. Among them, 174 (78%) patients had one treatment, while 49 (22%) needed a second treatment. The patients' status and treatment-related side effects were followed up. The complications rates after one HIFU in 223 patients were: urinary tract infection 0.4%, chronic pelvic pain 0.9%, infravesical obstruction 19.7%, stressincontinence 7.6%, impotence 49.8%. Among the 49 patients who received a second HIFU therapy, the cumulative incontinence rate (12.2%; P = 0.024) and cumulative impotence rate (55%; P < 0.001) were significantly increased. Although there is an increase in morbidity if transrectal HIFU is repeated, the risk of side effects related to additional HIFU sessions in the case of primary treatment failure is still low.

PMID:: 16850340; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Comparative Study

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Prostate Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

High-intensity focused ultrasound therapy for clinically localized prostate cancer. [Prostate Cancer Prostatic Dis....]
High-intensity focused ultrasound therapy for clinically localized prostate cancer.
Lee HM, Hong JH, Choi HY. Prostate Cancer Prostatic Dis. 2006; 9(4):439-43. Epub 2006 Jul 18.
High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up. [BJU Int. 2009]
High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
Challacombe BJ, Murphy DG, Zakri R, Cahill DJ. BJU Int. 2009 Jul; 104(2):200-4. Epub 2009 Feb 11.
Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use. [Prostate Cancer Prostatic Dis....]
Transrectal high-intensity focused ultrasound (HIFU) treatment of localized prostate cancer: review of technical incidents and morbidity after 5 years of use.
Ripert T, Azémar MD, Ménard J, Bayoud Y, Messaoudi R, Duval F, Staerman F. Prostate Cancer Prostatic Dis. 2010 Jun; 13(2):132-7. Epub 2010 Jan 5.
Review High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. [Urology. 2004]
Review High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
Blana A, Walter B, Rogenhofer S, Wieland WF. Urology. 2004 Feb; 63(2):297-300.
Review High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. [BJU Int. 2008]
Review High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.
Rebillard X, Soulié M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL, Coulange C, Association Francaise d'Urologie. BJU Int. 2008 May; 101(10):1205-13. Epub 2008 Mar 4.

See reviews... See all...

Cited by 3 PubMed Central articles

Preliminary safety and efficacy results with robotic high-intensity focused ultrasound : A single center Indian experience. [Indian J Urol. 2011]
Preliminary safety and efficacy results with robotic high-intensity focused ultrasound : A single center Indian experience.
Mishra S, Sharma R, Garg CP, Muthu V, Ganpule A, Sabnis RB, Desai MR. Indian J Urol. 2011 Jul; 27(3):331-6.
High intensity focused ultrasound in clinical tumor ablation. [World J Clin Oncol. 2011]
High intensity focused ultrasound in clinical tumor ablation.
Zhou YF. World J Clin Oncol. 2011 Jan 10; 2(1):8-27.
Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future. [Indian J Urol. 2010]
Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future.
Mearini L, Porena M. Indian J Urol. 2010 Jan-Mar; 26(1):4-11.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Morbidity associated with repeated transrectal high-intensity focused ultrasound...
Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer.
World J Urol. 2006 Nov ;24(5):585-90. Epub 2006 Jul 19 .

PubMed
Trastuzumab and breast cancer: developments and current status.
Trastuzumab and breast cancer: developments and current status.
Int J Clin Oncol. 2006 Jun ;11(3):199-208.

PubMed
Injection therapy for enthesopathies causing axial spine pain and the "failed ba...
Injection therapy for enthesopathies causing axial spine pain and the "failed back syndrome": a single blinded, randomized and cross-over study.
Pain Physician. 2005 Apr ;8(2):167-73.

PubMed
Adding a dialysis dose to continuous hemofiltration increases survival in patien...
Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
Kidney Int. 2006 Oct ;70(7):1312-7. Epub 2006 Jul 19 .

PubMed
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxalu...
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
Kidney Int. 2006 Oct ;70(7):1305-11. Epub 2006 Jul 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: